期刊文献+

红霉素衍生物LY267108在抑制单核细胞增殖过程中对核因子-κB活化的影响 被引量:1

Effect of erythromycin derivatives on activation of nuclear factor-kappa B during its inhibition procedure on monocyte proliferation
下载PDF
导出
摘要 目的通过观察红霉素衍生物LY267108对单核细胞增殖和核因子-κB(NF-κB)表达的影响,探讨红霉素衍生物抗炎作用的机制。方法以红霉素为对照,用四氮唑盐(MTT)还原法观察LY267108对单核细胞增殖的影响;用反转录-聚合酶链式反应(RT-PCR)和Western Blot方法观察LY267108对单核细胞NF-κB表达的影响。结果LY267108和红霉素均可抑制单核细胞的增殖,其IC50值分别为154.9、493.4μmol.L-1;RT-PCR和Western Blot测定结果显示LY267108可抑制单核细胞NF-κB mRNA和蛋白的表达,并与剂量之间呈现负相关。结论红霉素衍生物LY267108的抗炎活性可能与其抑制炎症细胞增殖和影响NF-κB活化有关。 Objective To observe the effects of erythromycin derivative LY267108 on the proliferation and the expression of nuclear factor-kappa B(NF-κB)of monocyte and study the anti-inflammatory mechanism of erythromycin derivatives. Methods The effects of LY267108 on the proliferation were evaluated by monotetrazolium test assay (MTT assay) ;monocytes were exposed to 100 μmol·L^-1 TNF-α with or without pretreatment with 3, 10, 30 or 100 mg· L^-1 of LY267108 1 h at 37 ℃. The expression of NF-κB was observed by reverse transcription-polymerase chain reaction(RT-PCR) and by Western Blot. Results The proliferation of monocyte was inhibited by LY267108 and erythromycin with IC50 of 154. 9 μmol·L^-1 and 493.4 μmol·L^-1 , respectively; LY267108 decreased the expressions of NF-κB mRNA and protein in a doserelated fashion. Conclusions The anti-inflammatory activity of erythromycin derivatives maybe due partly to the interaction with the proliferation and NF-κB signaling pathway in inflammatory cells.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2008年第6期489-492,共4页 Journal of Shenyang Pharmaceutical University
基金 沈阳市科技计划技术创新开发基金资助项目(1053125-1-49)
关键词 红霉素衍生物 抗炎活性 单核细胞 增殖 核因子-ΚB erythromycin derivative anti-inflammatory activity monocyte proliferation nuclear factor- kappa B
  • 相关文献

参考文献7

  • 1DAVIDSON R, PELOQUIN L. Anti-Inflammatory effects of the macrolides [J]. J Otolaryngol, 2002, 31 (suppl 1) : S38 - 40.
  • 2KEICHO N, KUDOH S. Disffuse panbronchiolitis: Role of macrolides in therapy []]. Am J Resplr Med, 2002,1 (2):119 - 131.
  • 3KIBWAGE I O, JANSSEN G, BUSSON R, et al. Translactonization in erythromycins [ J ]. J Org Chem,1987,52(19):990 - 996.
  • 4JOHNSTON S L. Macrolide antibiotics and asthma treatment [J].J Allergy Clin Immunol, 2006, 117(6): 1233 - 1236.
  • 5CAZZOLA M, SALZILLO A, DIAMARE F. Potential role of macrolides in the treatment of asthma [J]. Monaldi Arch Chest Dis, 2000, 55(3):231 -236.
  • 6SAKITO O, KADOTA J, KOHNO F, et al. Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis:A potential mechanism of macrolide therapy [J]. Respiration, 1996, 63(1) :42 - 48.
  • 7SCHULTZ M, SPEELMAN P, ZAAT S, et al. Erythromycin inhibits tumour necrosis factor alpha killed and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood [J]. Antimicrob Agents Chemother, 1998, 42(7) : 1605 - 1609.

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部